financetom
Business
financetom
/
Business
/
What's Going On With Blackstone Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Blackstone Stock Today?
Nov 9, 2024 11:29 AM

Blackstone shares are trading higher on Wednesday.

In fact, several banking and private equity shares traded higher after Donald Trump won the U.S. presidential election.

Meanwhile, Blackstone Real Estate Partners X has agreed to acquire all outstanding shares of Retail Opportunity Investments Corp. ( ROIC ) for $17.50 per share.

The all-cash deal is valued at approximately $4 billion, including Retail Opportunity Investments’ outstanding debt.

The purchase price represents a premium of 34% to Retail Opportunity Investments’ closing share price on July 29, the last trading day prior to news reports of a potential sale.

“We are pleased to be acquiring ROIC, which owns a unique collection of high-quality assets in some of the most desirable West Coast markets,” said Jacob Werner, Co-Head of Americas Acquisitions at Blackstone Real Estate.

The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.

Also Read: Stock Of The Day: Trump Media & Technology Hits Resistance, Reverses And Trends Lower

Retail Opportunity Investments’ portfolio comprises 93 grocery-anchored retail properties totaling 10.5 million square feet concentrated in Los Angeles, Seattle, San Francisco and Portland.

“The sector is experiencing accelerating fundamentals, benefiting from nearly a decade of virtually no new construction, while demand for brick-and-mortar grocery stores, restaurants, fitness and other lifestyle retailers remains healthy,” Werner added.

“We are confident that Blackstone will position ROIC’s portfolio for continued growth and success,” said Stuart A. Tanz, President and Chief Executive Officer of Retail Opportunity Investments ( ROIC ).

Price Action: ROIC shares traded higher by 4.28% to $17.30 at last check Wednesday, while BX shares traded higher by 4.03% to $176.46.

Image via Shutterstock

Read Next:

Trump Victory Sends Bank Stocks Higher, Leading S&P 500 On Regulatory Hopes

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Journey Medical Gets FDA Approval for Rosacea Treatment
Journey Medical Gets FDA Approval for Rosacea Treatment
Nov 4, 2024
11:12 AM EST, 11/04/2024 (MT Newswires) -- Journey Medical ( DERM ) said Monday the US Food and Drug Administration approved Emrosi for the treatment of inflammatory lesions of rosacea, an inflammatory skin condition, in adults. The company said it is completing the manufacturing of Emrosi for the US market, with initial supply expected to be available late in Q1...
BCE Strikes Roughly $5.04 Billion Deal to Buy Ziply Fiber
BCE Strikes Roughly $5.04 Billion Deal to Buy Ziply Fiber
Nov 4, 2024
10:54 AM EST, 11/04/2024 (MT Newswires) -- BCE (BCE) on Monday agreed to acquire US-based internet provider Ziply Fiber in a deal with a total value of about 7 billion Canadian dollars ($5.04 billion), including debt. The Canadian telecommunications company's subsidiary, Bell Canada, will buy Ziply for roughly CA$5 billion in cash and assume around CA$2 billion of its outstanding...
Arthur J. Gallagher Buys Statewide Commercial Insurance Brokers
Arthur J. Gallagher Buys Statewide Commercial Insurance Brokers
Nov 4, 2024
10:51 AM EST, 11/04/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Monday it acquired Statewide Commercial Insurance Brokers, a California-based retail property and casualty agency, specializing in insurance for construction contractors. Financial details weren't disclosed. The Statewide team will stay in their current location at Altadena, California and serve under Scott Firestone, who manages Arthur J. Gallagher's...
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
Nov 4, 2024
11:12 AM EST, 11/04/2024 (MT Newswires) -- Alvotech ( ALVO ) and Advanz Pharma said Monday that the European Medicines Agency accepted the marketing authorization application for AVT05 to treat several chronic inflammatory diseases. AVT05 is a biosimilar of Simponi and Simponi Aria, or golimumab, which are marketed by Johnson & Johnson's ( JNJ ) Janssen Biotech unit. The approvals...
Copyright 2023-2026 - www.financetom.com All Rights Reserved